← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1999Last known activity
Jul 1, 2025
Timeline
1960s
- Jun 1, 1968
Chimei Medical Center— Founded
Drugs by trial phase (54 distinct, 31 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anorexia
- Biliary Tract Diseases
- Cachexia
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cerebral Infarction
- Colonic Diseases
- Communicable Diseases
- Diabetic Foot
- Dizziness
- Endometrial Neoplasms
- Focal Infection
- Ganglion Cysts
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Infections
- Ischemia
- Lymphoma
- Lymphoma, Non-Hodgkin
- Meniere Disease
- Mouth Neoplasms
- Nasopharyngeal Carcinoma
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Rectal Neoplasms
- Recurrence
- Stroke
- Vertigo
- Weight Loss
Recent trials (38)
- NCT06903273CollaboratorPhase 2Jul 1, 2025
- NCT06447441OfficialN/AJul 1, 2024
- NCT06447441Lead sponsorN/AJul 1, 2024
- NCT06447441Sponsor investigatorN/AJul 1, 2024
- NCT06069141CollaboratorN/AOct 31, 2023
- NCT05514197Lead sponsorN/ASep 1, 2022
- NCT05514197Study directorN/ASep 1, 2022
- NCT04712058CollaboratorN/AJan 20, 2021
- NCT04619082CollaboratorPhase 4Dec 1, 2020
- NCT04030429CollaboratorPhase 2Jul 31, 2019
- NCT04015245Reponsible party - principal investigatorPhase 4Apr 12, 2018
- NCT04015245Lead sponsorPhase 4Apr 12, 2018
- NCT03024684CollaboratorPhase 4Jan 1, 2017
- NCT03891134Lead sponsorN/ADec 12, 2016
- NCT02959359CollaboratorPhase 4Nov 1, 2016
Details
- Founded
- Yunlin, TW Jun 1, 1968
- Last known activity
- Jul 1, 2025